Case Report

Carcinomatous Meningitis Secondary to Transitional Cell Bladder Cancer

Authors: Casey D. Bowen, MD, Gary Von Burton, MD, Rebecca C. Bargen, MD, Phillip Madonia, MD, Songlin Zhang, MD, PhD, Eduardo Gonzalez Toledo, MD, Richard Zweig, MD, Chaitanya Pant, MD

Abstract

We report a patient with carcinomatous meningitis secondary to known transitional cell carcinoma of the bladder. The patient presented with multiple focal neurological signs and symptoms. Diagnosis was suggested by magnetic resonance imaging and confirmed by analysis of the cerebrospinal fluid. He received whole brain radiotherapy despite a poor prognosis. To our knowledge, this is only the fifth reported case of neoplastic meningitis due to bladder cancer with confirmatory imaging and cytology and only the fourth reported case that presented with cranial nerve involvement.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Yap HY, Yap BS, Tashima CK, et al. Meningeal carcinomatosis in breast cancer. Cancer 1978;42:283–286.
 
2. Rosen ST, Aisner J, Makuch RW, et al. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine (Baltimore)1982;61:45–53.
 
3 . Aroney RS, Dalley DN, Chun WK, et al. Meningeal cancer in small cell carcinoma of the lung. Am J Med 1981;7:26–32.
 
4. Amer MH, Al-Sarraf M, Baker LH, et al. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 1978;42:660–668.
 
5. Chamberlain MC. Carcinomatous meningitis. Arch Neurol 1997;54:16–17.
 
6. Bruna J, Rojas-Marcos I, Martínez-Yelamos S, et al. Meningeal carcinomatosis as the first manifestation of a transitional cell carcinoma of the bladder. J Neurooncol 2003;63:63–67.
 
7. Cozzarini C, Reni M, Mangili F, et al. Meningeal carcinomatosis from transitional cell carcinoma of the bladder: report of two cases and review of the literature. Cancer Invest 1999;17:402–407.
 
8. Eng C, Cunningham D, Quade BJ, et al. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer 1993;72:553–557.
 
9. Juan Vidal O, de Paz Arias L, Catalá Barceló J, et al. Meningeal carcinomatosis as first manifestation of carcinoma of the bladder: report of 2 cases [in Spanish]. An Med Interna 2000;17:425–428.
 
10. Loizaga Iriarte A, Arciniega García JM, Infante Riaño R, et al. Meningeal carcinomatosis in bladder tumor [in Spanish]. Actas Urol Esp 1999;23:873–875.
 
11. Bloch JL, Nieh PT, Walzak MP. Brain metastases from transitional cell carcinoma. J Urol 1987;137:97–99.
 
12. Hust MH, Pfitzer P. Cerebrospinal fluid and metastasis of transitional cell carcinoma of the bladder. Acta Cytol 1982;26:217–223.
 
13. Hasbini A, Himberlin C, Beguinot I, et al. La meningite carcinomateuse: une complication rare du cancer de la vessie. Rev Med Interne 1997;18:402–406.
 
14. Hussein AM, Savaraj N, Feun LG, et al. Carcinomatous meningitis from transitional cell carcinoma of the bladder: case report. J Neurooncol 1989;7:255–260.
 
15. Imamura S, Nozawa I, Imamura M, et al. Clinicopathologic study of leptomeningeal carcinomatosis involving the temporal bone. Ann Otol Rhinol Laryngol 1997;106:674–679.
 
16. Mandell S, Wernz J, Morales P, et al. Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology 1985;25:520–521.
 
17. Santarossa S, Vaccher E, Balestreri L, et al. Solitary meningeal recurrence in a patient with transitional cell carcinoma of the bladder with locally bulky disease at presentation. J Neurooncol 1997;35:141–143.
 
18. Steg RE, Frank AR, Lefkowitz DM. Complex partial status epilepticus in a patient with dural metastases. Neurology 1993;43:2389–2392.
 
19. Bishop JR Jr, Moul JW, Maldonado L, et al. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy. Urology 1990;36:373–377.
 
20. Raghavan D, Chye RW. Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder. Br J Urol 1991;67:438–440.
 
21. Sugimori K, Kobayashi K, Hayashi M, et al. Leptomeningeal carcinomatosis from urinary bladder adenocarcinoma: a clinicopathological case study. Neuropathology 2005;25:89–94.
 
22. Chamberlain MC. Neoplastic meningitis. Oncologist 2008;13:967–977.
 
23. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759–772.
 
24. Balm M, Hammack J. Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 1996;53:626–632.
 
25. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103–119.